| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |